The joint ISPOR–ISPE Special Task Force on real-world evidence in health care decision making: an interview with Marc Berger
| Autor: | Marc L Berger |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Health economics business.industry 030503 health policy & services Health Policy Health services research Library science 03 medical and health sciences Pharmacoeconomics 0302 clinical medicine Analytics Health care Medicine 030212 general & internal medicine Outcomes research 0305 other medical science business Medicaid Health policy |
| Zdroj: | Journal of Comparative Effectiveness Research. 7:11-13 |
| ISSN: | 2042-6313 2042-6305 |
| DOI: | 10.2217/cer-2017-0082 |
| Popis: | Marc L Berger, MD, is a retired, part-time consultant. He recently became Chair of the Real World Evidence Advisory Board for SHYFT Analytics. Over a 25-year industry career, Marc has held senior-level positions at Pfizer, Inc., OptumInsight, Eli Lilly and Company, and Merck & Co., Inc. His professional activities have included serving on committees for Center for Medicare and Medicaid Services (CMS), Agency for Healthcare Research and Quality (AHRQ), Patient-Centered Outcomes Research Institute (PCORI), the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Drug Information Association (DIA), and the editorial advisory boards of several journals. Marc has written or co-written more than 100 peer-reviewed articles, book chapters, and other publications on a range of topics including health services research, outcomes research, health economics, health policy, and the analysis of real-world data. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|